On the public citation graph
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
0 signed · 478 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/adfm.201703036openalex-snapshot
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
inferredcites →https://doi.org/10.1002/adma.201705737openalex-snapshot
In Situ shRNA Synthesis on DNA–Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer
inferredcites →https://doi.org/10.1002/advs.201700964openalex-snapshot
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
inferredcites →https://doi.org/10.1002/anie.201101554openalex-snapshot
Differentially Charged Hollow Core/Shell Lipid–Polymer–Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
inferredcites →https://doi.org/10.1002/cncr.22381openalex-snapshot
Prognostic markers in triple‐negative breast cancer
inferredcites →https://doi.org/10.1002/ijc.10799openalex-snapshot
A prospective study of adiposity and postmenopausal breast cancer risk: The Malmö diet and cancer study
inferredcites →https://doi.org/10.1002/ijc.31914openalex-snapshot
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study
inferredcites →https://doi.org/10.1002/stem.1058openalex-snapshot
Radiation‐Induced Reprogramming of Breast Cancer Cells
inferredcites →https://doi.org/10.1007/978-3-319-70197-4_10openalex-snapshot
Immune Checkpoint Blockade for Breast Cancer
inferredcites →https://doi.org/10.1007/s10549-017-4624-7openalex-snapshot
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer
inferredcites →https://doi.org/10.1007/s10948-017-4199-xopenalex-snapshot
Luteolin-Loaded Spion as a Drug Carrier for Cancer Cell In Vitro
inferredcites →https://doi.org/10.1007/s11095-016-2077-zopenalex-snapshot
Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers
inferredcites →https://doi.org/10.1007/s13277-015-4402-2openalex-snapshot
Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs
inferredcites →https://doi.org/10.1016/b978-0-08-102198-9.00004-1openalex-snapshot
Clinical applications of nanostructured drug delivery systems
inferredcites →https://doi.org/10.1016/j.addr.2012.07.018openalex-snapshot
Mesoporous silica nanoparticles in medicine—Recent advances
inferredcites →https://doi.org/10.1016/j.ajps.2018.03.002openalex-snapshot
Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors
inferredcites →https://doi.org/10.1016/j.amjms.2017.08.002openalex-snapshot
Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles
inferredcites →https://doi.org/10.1016/j.apsb.2016.02.001openalex-snapshot
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
inferredcites →https://doi.org/10.1016/j.bbagrm.2019.04.005openalex-snapshot
Non-coding RNAs as potential therapeutic targets in breast cancer
inferredcites →https://doi.org/10.1016/j.bcp.2012.07.012openalex-snapshot
Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
inferredcites →https://doi.org/10.1016/j.biomaterials.2008.10.062openalex-snapshot
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles
inferredcites →https://doi.org/10.1016/j.biomaterials.2011.12.052openalex-snapshot
The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2012.06.056openalex-snapshot
Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.09.043openalex-snapshot
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.10.011openalex-snapshot
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.11.083openalex-snapshot
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.12.089openalex-snapshot
Dynamic disordering of liposomal cocktails and the spatio-temporal favorable release of cargoes to circumvent drug resistance
inferredcites →https://doi.org/10.1016/j.biomaterials.2014.08.033openalex-snapshot
Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets
inferredcites →https://doi.org/10.1016/j.biomaterials.2014.12.030openalex-snapshot
Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery
inferredcites →https://doi.org/10.1016/j.biomaterials.2015.12.014openalex-snapshot
Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition
inferredcites →https://doi.org/10.1016/j.biomaterials.2017.10.048openalex-snapshot
Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer
inferredcites →https://doi.org/10.1016/j.biopha.2017.12.087openalex-snapshot
Breast cancer: Lesser-known facets and hypotheses
inferredcites →https://doi.org/10.1016/j.biopha.2018.06.066openalex-snapshot
Clinical and molecular aspects of breast cancer: Targets and therapies
inferredcites →https://doi.org/10.1016/j.breastdis.2013.01.026openalex-snapshot
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
inferredcites →https://doi.org/10.1016/j.cbi.2014.09.025openalex-snapshot
Synthesis and characterisation of morin reduced gold nanoparticles and its cytotoxicity in MCF-7 cells
inferredcites →https://doi.org/10.1016/j.cell.2013.06.005openalex-snapshot
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
inferredcites →https://doi.org/10.1016/j.cell.2013.06.044openalex-snapshot
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
inferredcites →https://doi.org/10.1016/j.clbc.2017.07.013openalex-snapshot
Alarming Burden of Triple-Negative Breast Cancer in India
inferredcites →https://doi.org/10.1016/j.cmet.2017.11.001openalex-snapshot
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
inferredcites →https://doi.org/10.1016/j.colsurfb.2011.02.040openalex-snapshot
Anti-tumor efficacy of polymer–platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice
inferredcites →https://doi.org/10.1016/j.colsurfb.2013.08.032openalex-snapshot
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
inferredcites →https://doi.org/10.1016/j.drudis.2014.05.002openalex-snapshot
Chemical approaches to targeting drug resistance in cancer stem cells
inferredcites →https://doi.org/10.1016/j.ejpb.2017.07.003openalex-snapshot
CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition
inferredcites →https://doi.org/10.1016/j.ejpb.2019.01.017openalex-snapshot
Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer
inferredcites →https://doi.org/10.1016/j.electacta.2016.03.198openalex-snapshot
Highly Water-soluble and Surface Charge-tunable Fluorescent Fullerene Nanoparticles: Facile Fabrication and Cellular Imaging
inferredcites →https://doi.org/10.1016/j.fct.2017.07.020openalex-snapshot
Nanomedicine and epigenome. Possible health risks
inferredcites →https://doi.org/10.1016/j.fjps.2018.06.001openalex-snapshot
Anticancer effects of silver nanoparticles encapsulated by Gloriosa superba (L.) leaf extracts in DLA tumor cells
inferredcites →https://doi.org/10.1016/j.ijbiomac.2015.02.011openalex-snapshot
Anti-cancer evaluation of quercetin embedded PLA nanoparticles synthesized by emulsified nanoprecipitation
inferredcites →https://doi.org/10.1016/j.ijbiomac.2018.12.003openalex-snapshot
Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy
inferredcites →https://doi.org/10.1016/j.ijpharm.2010.04.002openalex-snapshot
Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells
inferredcites →https://doi.org/10.1016/j.ijpharm.2014.06.058openalex-snapshot
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer
inferredcites →https://doi.org/10.1016/j.ijpharm.2017.06.026openalex-snapshot
In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells
inferredcites →https://doi.org/10.1016/j.ijpharm.2018.04.061openalex-snapshot
Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity
inferredcites →https://doi.org/10.1016/j.ijpharm.2018.12.022openalex-snapshot
Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model
inferredcites →https://doi.org/10.1016/j.jconrel.2012.03.020openalex-snapshot
Doxil® — The first FDA-approved nano-drug: Lessons learned
inferredcites →https://doi.org/10.1016/j.jconrel.2012.08.020openalex-snapshot
Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex
inferredcites →https://doi.org/10.1016/j.jconrel.2014.11.011openalex-snapshot
Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
inferredcites →https://doi.org/10.1016/j.jconrel.2018.10.030openalex-snapshot
Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer
inferredcites →https://doi.org/10.1016/j.jconrel.2019.12.005openalex-snapshot
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
inferredcites →https://doi.org/10.1016/j.lfs.2019.117009openalex-snapshot
Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
inferredcites →https://doi.org/10.1016/j.msec.2016.04.044openalex-snapshot
Curcumin loaded gum arabic aldehyde-gelatin nanogels for breast cancer therapy
inferredcites →https://doi.org/10.1016/j.msec.2018.10.071openalex-snapshot
RETRACTED: Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model
inferredcites →https://doi.org/10.1016/j.nano.2013.10.006openalex-snapshot
A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing
inferredcites →https://doi.org/10.1016/j.nano.2015.07.001openalex-snapshot
Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway
inferredcites →https://doi.org/10.1016/j.nano.2016.04.011openalex-snapshot
Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma
inferredcites →https://doi.org/10.1016/j.nano.2019.04.006openalex-snapshot
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
inferredcites →https://doi.org/10.1016/j.omtn.2017.03.007openalex-snapshot
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer
inferredcites →https://doi.org/10.1016/j.semcancer.2016.08.006openalex-snapshot
Bioactive natural products in cancer prevention and therapy: Progress and promise
inferredcites →https://doi.org/10.1016/j.stemcr.2013.11.009openalex-snapshot
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
inferredcites →https://doi.org/10.1016/s0140-6736(11)61625-5openalex-snapshot
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
inferredcites →https://doi.org/10.1016/s1040-1741(08)70294-xopenalex-snapshot
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials
inferredcites →https://doi.org/10.1016/s1470-2045(16)00106-6openalex-snapshot
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.5b00900openalex-snapshot
Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal Model
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b00430openalex-snapshot
Tumor-Targeting Micelles Based on Linear–Dendritic PEG–PTX8 Conjugate for Triple Negative Breast Cancer Therapy
inferredcites →https://doi.org/10.1021/acsami.7b13328openalex-snapshot
Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery
inferredcites →https://doi.org/10.1021/bc8002452openalex-snapshot
Specific Targeting of HER2 Overexpressing Breast Cancer Cells with Doxorubicin-Loaded Trastuzumab-Modified Human Serum Albumin Nanoparticles
inferredcites →https://doi.org/10.1021/mp400311jopenalex-snapshot
Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced Toxicity
inferredcites →https://doi.org/10.1021/nn3044066openalex-snapshot
Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
inferredcites →https://doi.org/10.1021/nn402043copenalex-snapshot
In Vivo Biodistribution and Toxicology of Carboxylated Graphene Quantum Dots
inferredcites →https://doi.org/10.1021/nn800275ropenalex-snapshot
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
inferredcites →https://doi.org/10.1021/nn900918wopenalex-snapshot
Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs
inferredcites →https://doi.org/10.1038/am.2017.185openalex-snapshot
Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
inferredcites →https://doi.org/10.1038/nature17038openalex-snapshot
Metastatic colonization by circulating tumour cells
inferredcites →https://doi.org/10.1038/ncomms6988openalex-snapshot
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
inferredcites →https://doi.org/10.1038/ncomms8122openalex-snapshot
C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling
inferredcites →https://doi.org/10.1038/nrd1632openalex-snapshot
Recent advances with liposomes as pharmaceutical carriers
inferredcites →https://doi.org/10.1038/s41467-018-06893-9openalex-snapshot
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
inferredcites →https://doi.org/10.1038/s41565-018-0356-zopenalex-snapshot
Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
inferredcites →https://doi.org/10.1038/sj.clpt.6100296openalex-snapshot
Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies
inferredcites →https://doi.org/10.1038/sj.onc.1204452openalex-snapshot
Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E–cdk2 complexes
inferredcites →https://doi.org/10.1038/srep26895openalex-snapshot
Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity
inferredcites →https://doi.org/10.1038/srep34053openalex-snapshot
Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy
inferredcites →https://doi.org/10.1038/srep35267openalex-snapshot
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
inferredcites →https://doi.org/10.1039/c1nr10573fopenalex-snapshot
Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system
inferredcites →https://doi.org/10.1039/c1sm05324hopenalex-snapshot
Biodegradable polymeric microcapsules for selective ultrasound-triggered drug release
inferredcites →https://doi.org/10.1039/c6ra11658bopenalex-snapshot
Induction of intrinsic apoptotic pathway and cell cycle arrest via baicalein loaded iron oxide nanoparticles as a competent nano-mediated system for triple negative breast cancer therapy
inferredcites →https://doi.org/10.1039/c8nr02796jopenalex-snapshot
How can nanotechnology help the fight against breast cancer?
inferredcites →https://doi.org/10.1042/bsr20171357openalex-snapshot
Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa052122openalex-snapshot
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa072113openalex-snapshot
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1109653openalex-snapshot
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1706450openalex-snapshot
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
inferredcites →https://doi.org/10.1056/nejmra043186openalex-snapshot
Trastuzumab — Mechanism of Action and Use in Clinical Practice
inferredcites →https://doi.org/10.1056/nejmsr1504363openalex-snapshot
Breast-Cancer Screening — Viewpoint of the IARC Working Group
inferredcites →https://doi.org/10.1073/pnas.89.10.4285openalex-snapshot
Humanization of an anti-p185HER2 antibody for human cancer therapy.
inferredcites →https://doi.org/10.1074/jbc.275.11.8027openalex-snapshot
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
inferredcites →https://doi.org/10.1080/02652048.2017.1340355openalex-snapshot
Lipid Based nanoformulation of lycopene improves oral delivery: formulation optimization, ex vivo assessment and its efficacy against breast cancer
inferredcites →https://doi.org/10.1080/1061186x.2018.1523418openalex-snapshot
Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics
inferredcites →https://doi.org/10.1080/10717540590968855openalex-snapshot
Solid Lipid Nanoparticles Containing Tamoxifen Characterization andIn VitroAntitumoral Activity
inferredcites →https://doi.org/10.1080/10717544.2019.1576801openalex-snapshot
pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer
inferredcites →https://doi.org/10.1080/15548627.2016.1162930openalex-snapshot
Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin
inferredcites →https://doi.org/10.1080/21691401.2017.1366337openalex-snapshot
Nanocarrier based approaches for targeting breast cancer stem cells
inferredcites →https://doi.org/10.1088/1361-6528/aaf51bopenalex-snapshot
Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro
inferredcites →https://doi.org/10.1091/mbc.e04-07-0591openalex-snapshot
Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin
inferredcites →https://doi.org/10.1093/annonc/mdp062openalex-snapshot
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
inferredcites →https://doi.org/10.1093/annonc/mds324openalex-snapshot
Neoadjuvant treatment of breast cancer
inferredcites →https://doi.org/10.1093/annonc/mdx505openalex-snapshot
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
inferredcites →https://doi.org/10.1093/carcin/bgn269openalex-snapshot
A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF- B-signaling pathways
inferredcites →https://doi.org/10.1093/jnci/93.16.1215openalex-snapshot
Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast Cancer
inferredcites →https://doi.org/10.1097/gme.0b013e3181788d88openalex-snapshot
Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer
inferredcites →https://doi.org/10.1111/j.2042-7158.2011.01376.xopenalex-snapshot
Cellular delivery of PEGylated PLGA nanoparticles
inferredcites →https://doi.org/10.1111/jphp.13098openalex-snapshot
An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites
inferredcites →https://doi.org/10.1126/science.1203543openalex-snapshot
A Perspective on Cancer Cell Metastasis
inferredcites →https://doi.org/10.1126/science.1225829openalex-snapshot
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
inferredcites →https://doi.org/10.1126/science.279.5349.377openalex-snapshot
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
inferredcites →https://doi.org/10.1136/esmoopen-2017-000208openalex-snapshot
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
inferredcites →https://doi.org/10.1155/2013/165981openalex-snapshot
Lipid-Based Nanoparticles in Cancer Diagnosis and Therapy
inferredcites →https://doi.org/10.1155/2013/281230openalex-snapshot
The Role of Magnetic Nanoparticles in the Localization and Treatment of Breast Cancer
inferredcites →https://doi.org/10.1155/2015/182835openalex-snapshot
Natural Bioactives in Cancer Treatment and Prevention
inferredcites →https://doi.org/10.1155/2018/2058613openalex-snapshot
Carbon Nanomaterials for Breast Cancer Treatment
inferredcites →https://doi.org/10.1155/2018/4924186openalex-snapshot
Gloriosa superba Mediated Synthesis of Platinum and Palladium Nanoparticles for Induction of Apoptosis in Breast Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-06-1464openalex-snapshot
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
inferredcites →https://doi.org/10.1158/0008-5472.can-14-3485openalex-snapshot
Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-0220openalex-snapshot
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-1732openalex-snapshot
Advances in Targeting Human Epidermal Growth Factor Receptor-2 Signaling for Cancer Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-0288openalex-snapshot
Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
inferredcites →https://doi.org/10.1158/1535-7163.mct-06-0141openalex-snapshot
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
inferredcites →https://doi.org/10.1158/2159-8290.cd-15-0327openalex-snapshot
Tumor Twitter: Cellular Communication in the Breast Cancer Stem Cell Niche
inferredcites →https://doi.org/10.1159/000433622openalex-snapshot
Targeted Therapies in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1186/1476-4598-13-256openalex-snapshot
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
inferredcites →https://doi.org/10.1186/bcr432openalex-snapshot
Liposome-based drug delivery in breast cancer treatment
inferredcites →https://doi.org/10.1186/s11671-016-1586-3openalex-snapshot
Use of Baicalin-Conjugated Gold Nanoparticles for Apoptotic Induction of Breast Cancer Cells
inferredcites →https://doi.org/10.1186/s12937-016-0217-2openalex-snapshot
An overview on the role of dietary phenolics for the treatment of cancers
inferredcites →https://doi.org/10.1186/s13058-015-0615-yopenalex-snapshot
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
inferredcites →https://doi.org/10.1200/jco.2012.43.7251openalex-snapshot
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
inferredcites →https://doi.org/10.1200/jco.2012.46.2408openalex-snapshot
Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2015.64.8931openalex-snapshot
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
inferredcites →https://doi.org/10.1371/journal.pntd.0005995openalex-snapshot
Application of a loop-mediated isothermal amplification (LAMP) assay targeting cox1 gene for the detection of Clonorchis sinensis in human fecal samples
inferredcites →https://doi.org/10.1590/s1679-45082016rb3475openalex-snapshot
Advances in the use of nanocarriers for cancer diagnosis and treatment
inferredcites →https://doi.org/10.1634/theoncologist.10-90003-20openalex-snapshot
Extending Survival with Chemotherapy in Metastatic Breast Cancer
inferredcites →https://doi.org/10.18632/oncotarget.3348openalex-snapshot
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via “differentiation-based nano-therapy”
inferredcites →https://doi.org/10.18632/oncotarget.6672openalex-snapshot
The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma
inferredcites →https://doi.org/10.21037/sci.2017.11.03openalex-snapshot
Breast cancer stem cells—from origins to targeted therapy
inferredcites →https://doi.org/10.2147/bctt.s175360openalex-snapshot
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
inferredcites →https://doi.org/10.2147/ijn.s144184openalex-snapshot
Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
inferredcites →https://doi.org/10.2147/ijn.s179095openalex-snapshot
In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells
inferredcites →https://doi.org/10.2147/ijn.s204443openalex-snapshot
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers
inferredcites →https://doi.org/10.2147/ijn.s24185openalex-snapshot
Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
inferredcites →https://doi.org/10.2147/ijn.s36654openalex-snapshot
Targeted therapy using nanotechnology: focus on cancer
inferredcites →https://doi.org/10.2147/ijn.s78498openalex-snapshot
Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells
inferredcites →https://doi.org/10.2147/ijn.s78988openalex-snapshot
Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells
inferredcites →https://doi.org/10.2174/1381612823666170829164828openalex-snapshot
Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer
inferredcites →https://doi.org/10.2174/1389201015666140113110746openalex-snapshot
In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles
inferredcites →https://doi.org/10.2174/2211550104666151008213153openalex-snapshot
Nanoparticle Coated Viral Vectors for Gene Therapy
inferredcites →https://doi.org/10.2217/fon-2018-0131openalex-snapshot
Antibody–Drug Conjugates in Triple Negative Breast Cancer
inferredcites →https://doi.org/10.2217/nnm.12.180openalex-snapshot
Incorporation of Lapatinib Into Lipoprotein-Like Nanoparticles with Enhanced Water Solubility and Anti-Tumor Effect in Breast Cancer
inferredcites →https://doi.org/10.2217/nnm.12.22openalex-snapshot
Cancer Stem Cells and Drug Resistance: The Potential of Nanomedicine
inferredcites →https://doi.org/10.2217/nnm.15.86openalex-snapshot
Cancer Nanomedicine: Addressing the Dark Side of the Enhanced Permeability and Retention Effect
inferredcites →https://doi.org/10.3109/10717544.2013.834412openalex-snapshot
Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells
inferredcites →https://doi.org/10.3109/10717544.2015.1092183openalex-snapshot
Lipid-based nanocarriers for breast cancer treatment – comprehensive review
inferredcites →https://doi.org/10.3109/21691401.2016.1160912openalex-snapshot
Development and characterization of surface engineered PPI dendrimers for targeted drug delivery
inferredcites →https://doi.org/10.3322/caac.21412openalex-snapshot
Breast cancer statistics, 2017, racial disparity in mortality by state
inferredcites →https://doi.org/10.3322/caac.21492openalex-snapshot
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
inferredcites →https://doi.org/10.3322/caac.21557openalex-snapshot
Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
inferredcites →https://doi.org/10.3389/fphar.2016.00084openalex-snapshot
Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting
inferredcites →https://doi.org/10.3389/fphar.2016.00313openalex-snapshot
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
inferredcites →https://doi.org/10.3390/cancers12010187openalex-snapshot
Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer
inferredcites →https://doi.org/10.3390/cryst8100369openalex-snapshot
Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents
inferredcites →https://doi.org/10.3390/ijms19103264openalex-snapshot
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
inferredcites →https://doi.org/10.3390/molecules22091401openalex-snapshot
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
inferredcites →https://doi.org/10.3390/molecules22111814openalex-snapshot
Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells
inferredcites →https://doi.org/10.3390/nano10030455openalex-snapshot
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
inferredcites →https://doi.org/10.3892/ol.2018.8304openalex-snapshot
Phytochemicals: Current strategies for treating breast cancer (Review)
inferredcites →https://doi.org/10.3945/an.114.008052openalex-snapshot
Genistein and Cancer: Current Status, Challenges, and Future Directions
inferredcites →https://doi.org/10.4155/fdd-2019-0005openalex-snapshot
Perlecan-Targeted Nanoparticles for Drug Delivery to Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.4172/2157-7439.1000390openalex-snapshot
Gloriosa superba Mediated Synthesis of Silver and Gold Nanoparticles for Anticancer Applications
inferredcites →https://doi.org/10.7150/thno.7193openalex-snapshot
Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4755895openalex-extracted
In Vitro Investigation of Vitamin K3 and Doxorubicin Administration Regimens for Anticancer Activity in Free and Liposomal Forms
inferred← citeshttps://doi.org/10.1002/adtp.202400570openalex-snapshot
Polydopamine‐Integrated Nanomedicine through Dual Metabolic Intervention with Enhanced Photothermal Therapy against Triple‐Negative Breast Cancer
inferred← citeshttps://doi.org/10.1002/advs.202510171openalex-snapshot
Targeted Enrichment of Engineered Bacteria on Triple‐Negative Breast Cancer Turns Immunologically Cold Tumors Hot
inferred← citeshttps://doi.org/10.1002/bio.4353openalex-snapshot
Recent advances in nanomaterials‐based optical sensors for detection of various biomarkers (inorganic species, organic and biomolecules)
inferred← citeshttps://doi.org/10.1002/mba2.70012openalex-snapshot
Beyond Conventional Approaches: The Revolutionary Role of Nanoparticles in Breast Cancer
inferred← citeshttps://doi.org/10.1002/mog2.70044openalex-snapshot
Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience
inferred← citeshttps://doi.org/10.1002/ppsc.202100276openalex-snapshot
Current Strategies in Breast Cancer Therapy: Role of Epigenetics and Nanomedicine
inferred← citeshttps://doi.org/10.1002/ppsc.202400049openalex-snapshot
Nanoparticle‐Based Drug Delivery Platform for Simultaneous Administration of Phytochemicals and Chemotherapeutics: Emerging Trends in Cancer Management
inferred← citeshttps://doi.org/10.1002/slct.202404117openalex-snapshot
Construction of Sorafenib Tosylate and Etoposide‐loaded Liposomes: A Path to Precision Liver Cancer Therapy and its Apoptosis Induction
inferred← citeshttps://doi.org/10.1002/smll.202200179openalex-snapshot
Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous Cancers
inferred← citeshttps://doi.org/10.1002/wnan.1876openalex-snapshot
Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances
inferred← citeshttps://doi.org/10.1007/16833_2022_13openalex-snapshot
Nanostructured Lipid Carrier as a Strategy for the Treatment of Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-17831-3_1openalex-snapshot
Lipid Nanocarriers for Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-3-031-66421-2_9openalex-snapshot
Autophagy-Targeted Nanoparticles for the Treatment of Cancer
inferred← citeshttps://doi.org/10.1007/978-981-95-3682-5_20openalex-snapshot
Advancement in Metallic Nanoparticles for Diagnosis and Treatment of Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-981-97-8518-6_5openalex-snapshot
Breast Cancer-the-State-of-the Art in the World and Islamic Development Banks Members Countries (IsDB-MCs)
inferred← citeshttps://doi.org/10.1007/s00018-021-03850-6openalex-snapshot
Recent advances in liposome formulations for breast cancer therapeutics
inferred← citeshttps://doi.org/10.1007/s00210-024-03542-5openalex-snapshot
Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells
inferred← citeshttps://doi.org/10.1007/s00210-024-03778-1openalex-snapshot
The impact of graphene oxide nanoparticles on the migratory behavior of metastatic human breast cancer cell, MDA-MB-231
inferred← citeshttps://doi.org/10.1007/s00210-025-04916-zopenalex-snapshot
Design and characterization of phloretin-loaded PEG–lipid hybrid micelles for enhanced breast cancer therapy
inferred← citeshttps://doi.org/10.1007/s10495-026-02281-7openalex-snapshot
Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method
inferred← citeshttps://doi.org/10.1007/s10853-023-08605-1openalex-snapshot
Facile fabrication of silk sericin-coated zeolitic imidazolate framework-8 nanocarriers encapsulating cabazitaxel for the treatment of liver cancer cells and their cell death mechanism
inferred← citeshttps://doi.org/10.1007/s10867-023-09633-3openalex-snapshot
A biomechanical view of epigenetic tumor regulation
inferred← citeshttps://doi.org/10.1007/s10876-023-02417-8openalex-snapshot
Functionalization of Biosynthesized CQDs Capped AgO/ZnO Ternary Composite Against Microbes and Targeted Drug Delivery to Tumor Cells
inferred← citeshttps://doi.org/10.1007/s11033-024-09764-3openalex-snapshot
Ruxolitinib-loaded poly-ɛ-caprolactone (PCL) nanoparticles inhibit JAK2/STAT5 signaling in BT474 breast cancer cells by downregulating Bcl-2 and Mcl-1
inferred← citeshttps://doi.org/10.1007/s11033-025-10298-5openalex-snapshot
Phyto-mediated fabrication of silver nanoparticles from Scrophularia striata extract (AgNPs-SSE): a potential inducer of apoptosis in breast cancer cells
inferred← citeshttps://doi.org/10.1007/s11033-025-10638-5openalex-snapshot
Circular RNA rising star: new findings of circPRMT5 in cancer
inferred← citeshttps://doi.org/10.1007/s11095-022-03424-6openalex-snapshot
TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems
inferred← citeshttps://doi.org/10.1007/s12247-025-10043-2openalex-snapshot
Carrageenan Matrix for Sustained Levofloxacin Delivery: Formulation Strategies and Dual Evaluation Approaches
inferred← citeshttps://doi.org/10.1007/s12672-025-02014-3openalex-snapshot
Global trends and research hotspots in nanodrug delivery systems for breast cancer therapy: a bibliometric analysis (2013–2023)
inferred← citeshttps://doi.org/10.1007/s13237-025-00565-yopenalex-snapshot
Advances in camptothecin nanomedicine: enhancing targeted breast-cancer therapeutics using innovative drug delivery systems
inferred← citeshttps://doi.org/10.1007/s13346-024-01704-9openalex-snapshot
Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024
inferred← citeshttps://doi.org/10.1007/s40843-025-4001-xopenalex-snapshot
Inorganic biomaterials as immunomodulators: dual strategies for activation and suppression
inferred← citeshttps://doi.org/10.1016/b978-0-12-824476-0.00003-6openalex-snapshot
Breast cancer: introduction
inferred← citeshttps://doi.org/10.1016/b978-0-12-824476-0.00004-8openalex-snapshot
Targeting triple-negative breast cancers using nanomedicine
inferred← citeshttps://doi.org/10.1016/b978-0-323-85050-6.00014-1openalex-snapshot
Nano-pharmacokinetics and cancer theranostics
inferred← citeshttps://doi.org/10.1016/b978-0-323-85595-2.00013-xopenalex-snapshot
Solid lipid nanoparticles in photodynamic therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-33548-8.01005-3openalex-snapshot
Liposomes-mediated anticancer drug delivery approaches for the treatment of breast cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-40511-2.00022-xopenalex-snapshot
Targeting triple-negative breast cancer signaling via phytonanomedicine
inferred← citeshttps://doi.org/10.1016/b978-0-443-43870-7.00015-1openalex-snapshot
Breast cancer: IP landscape
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.04.038openalex-snapshot
Phosphorous dendrimer-mediated biomineralization for synergistic blockade therapy and hypoxia-activated chemotherapy of tumors
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.12.021openalex-snapshot
Cascade-amplified iron-doped bismuth sulfide biomimetic nanoplatform for synergistic therapy and multimodal imaging of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.adcanc.2025.100139openalex-snapshot
Investigating the apoptotic and antimetastatic effect of daphnetin-containing nano niosomes on MCF-7 cells
inferred← citeshttps://doi.org/10.1016/j.ajps.2023.100796openalex-snapshot
Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.arabjc.2023.105229openalex-snapshot
Core-shell iron oxide-platinium@metal organic framework/epirubicin nanospheres: Synthesis, characterization and anti-breast cancer activity
inferred← citeshttps://doi.org/10.1016/j.bbagen.2023.130396openalex-snapshot
Folate receptor targeted NIR cleavable liposomal delivery system augment penetration and therapeutic efficacy in breast cancer
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2025.120047openalex-snapshot
Loss of Prominin 2 expression inhibits AKT/mTOR signaling to limit glycolysis and drive ferroptosis in breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.188915openalex-snapshot
Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2025.06.034openalex-snapshot
Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2026.02.027openalex-snapshot
Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
inferred← citeshttps://doi.org/10.1016/j.bioadv.2022.213085openalex-snapshot
Transpapillary iontophoretic delivery of resveratrol loaded transfersomes for localized delivery to breast cancer
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108322openalex-snapshot
Gold nanoparticles-based targeted delivery of rapamycin and Olaparib to breast cancer: An in vitro and in vivo approach
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.114165openalex-snapshot
Marine life as a source for breast cancer treatment: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118224openalex-snapshot
Nanotechnology-mediated precision drug delivery strategies for breast cancer treatment
inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119795openalex-snapshot
Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2024.216842openalex-snapshot
SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG
inferred← citeshttps://doi.org/10.1016/j.cbi.2022.110094openalex-snapshot
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice
inferred← citeshttps://doi.org/10.1016/j.cej.2025.170316openalex-snapshot
Theranostic nanoplatform for triple-negative breast cancer therapy: Autophagy suppression-coordinated siRNA delivery triggers apoptosis, ferroptosis, and pyroptosis via photothermal activation
inferred← citeshttps://doi.org/10.1016/j.chmed.2026.02.012openalex-snapshot
Rhein/Fe3+ nanoassembly for triple-negative breast cancer treatment via a ferroptosis and immunogenic death
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2022.112422openalex-snapshot
Targeted delivery of albumin nanoparticles for breast cancer: A review
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2023.113381openalex-snapshot
Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.cpt.2025.03.005openalex-snapshot
Arthropod venom peptides: Nanotechnology-enabled delivery and therapeutic potential in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2022.103901openalex-snapshot
Inhibition of WNT signaling by conjugated microRNA nano-carriers: A new therapeutic approach for treating triple-negative breast cancer a perspective review
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2024.104417openalex-snapshot
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2025.104715openalex-snapshot
Novel strategies in breast cancer management: From treatment to long-term remission
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.06.007openalex-snapshot
Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2023.100116openalex-snapshot
Targeting breast cancer using phytoconstituents: Nanomedicine-based drug delivery
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114321openalex-snapshot
Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ejpb.2026.115126openalex-snapshot
Shine bright, then fight: lectin-decorated gold nanostars for cancer theranostics
inferred← citeshttps://doi.org/10.1016/j.ejps.2022.106212openalex-snapshot
Honokiol nanosuspensions loaded thermosensitive hydrogels as the local delivery system in combination with systemic paclitaxel for synergistic therapy of breast cancer
inferred← citeshttps://doi.org/10.1016/j.gene.2026.150201openalex-snapshot
The VEGF/VEGFR axis in triple-negative breast cancer: a comprehensive review of therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2021.11.095openalex-snapshot
Application of chitosan modified nanocarriers in breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.09.157openalex-snapshot
CD44-targeted nanoparticles with GSH-responsive activity as powerful therapeutic agents against breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.124647openalex-snapshot
Hybrid lipid-biopolymer nanocarrier as a strategy for GBM photodynamic therapy (PDT)
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.130168openalex-snapshot
Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.132074openalex-snapshot
Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.145947openalex-snapshot
Advances in chitosan-based nanofiber for breast cancer treatment: A review
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.146920openalex-snapshot
Dextran-engineered Cu-MOF nanozyme with multi-enzyme mimetic cascade for cuproptosis-enhanced synergistic therapy in triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.120835openalex-snapshot
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.120877openalex-snapshot
Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2022.121926openalex-snapshot
Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2022.121969openalex-snapshot
Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.123226openalex-snapshot
F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.123392openalex-snapshot
Identifying synergistic combinations of Doxorubicin-Loaded polyquercetin nanoparticles and natural Products: Implications for breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.125048openalex-snapshot
Lipid nanosystems for fatty liver therapy and targeted medication delivery: a comprehensive review
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.125142openalex-snapshot
Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.126994openalex-snapshot
In situ forming hydrogel incorporating celastrol-loaded copper-doped Prussian blue nanoparticles for oxidative stress amplified multimodal breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ijpx.2024.100314openalex-snapshot
Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.inoche.2022.109915openalex-snapshot
A strategy for the treatment of lung carcinoma by in situ immobilization of Ag nanoparticles on the surface of Fe3O4 nanoparticles that modified by lignin
inferred← citeshttps://doi.org/10.1016/j.inoche.2023.111092openalex-snapshot
Green tea extract bio-templated synthesis of Ag NPs immobilized magnetic nanocomposite: Evaluation of its catalytic activity and its performance for the treatment of gastrointestinal system cancers
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115728openalex-snapshot
Nanotechnology-based immunotherapy, an emerging paradigm in breast cancer therapeutics
inferred← citeshttps://doi.org/10.1016/j.jare.2023.02.005openalex-snapshot
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.jcis.2025.138085openalex-snapshot
Planar conjugate donor engineering enhanced photodynamic immunogenic cell death stimulator for efficient Triple-Negative breast cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.10.063openalex-snapshot
pH-Activatable cell penetrating peptide dimers for potent delivery of anticancer drug to triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.03.039openalex-snapshot
Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.07.014openalex-snapshot
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.08.047openalex-snapshot
Simultaneous inhibition of breast cancer and its liver and lung metastasis by blocking inflammatory feed-forward loops
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.01.010openalex-snapshot
Emerging nanomedicines of paclitaxel for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.04.014openalex-snapshot
Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.11.009openalex-snapshot
Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.07.074openalex-snapshot
Synergistic anticancer immunity in metastatic triple-negative breast cancer through an in situ amplifying Peptide-Drug Conjugate
inferred← citeshttps://doi.org/10.1016/j.jddst.2021.102725openalex-snapshot
Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines
inferred← citeshttps://doi.org/10.1016/j.jddst.2021.102883openalex-snapshot
Can nanotechnology overcome challenges facing stem cell therapy? A review
inferred← citeshttps://doi.org/10.1016/j.jddst.2022.104042openalex-snapshot
Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105389openalex-snapshot
Temperature/redox dual-responsive self-assembled nanogels for targeting delivery of curcumol to enhance anti-tumor and anti-metastasis activities against breast cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105401openalex-snapshot
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106411openalex-snapshot
Unveiling the challenges of short non-coding RNAs and their prospects in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.106979openalex-snapshot
Fabrication and characterization of calcium carbonate nanoparticles for delivery of doxorubicin in breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107224openalex-snapshot
Exquisite targeted delivery via Cerasome–Herceptin in HER2-positive human breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108755openalex-snapshot
Sequential co-delivery of gemcitabine and nintedanib via mPEG-PLG nanomicelles for enhanced breast cancer chemotherapy
inferred← citeshttps://doi.org/10.1016/j.jorganchem.2025.123701openalex-snapshot
Decorated silver nanoparticles over chitosan modified CNTs/Fe3O4 nanoparticles: A recyclable navel catalyst for solvent-free A3 coupling reactions and evaluation of its anti-breast cancer effects
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119110openalex-snapshot
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119576openalex-snapshot
Novel decorated nanostructured lipid carrier for simultaneous active targeting of three anti-cancer agents
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119667openalex-snapshot
Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells
inferred← citeshttps://doi.org/10.1016/j.mattod.2026.103283openalex-snapshot
Bioactive lipid nanoparticles as active rehabilitative regulators for fibrotic microenvironment remodeling
inferred← citeshttps://doi.org/10.1016/j.molstruc.2023.136688openalex-snapshot
Glycosylated zinc(II) phthalocyanine photosensitizer: Synthesis, photophysical properties and in vitro photodynamic activity on breast cancer cell line
inferred← citeshttps://doi.org/10.1016/j.mtbio.2022.100450openalex-snapshot
Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement
inferred← citeshttps://doi.org/10.1016/j.nanoso.2024.101405openalex-snapshot
Nanoparticle-based photodynamic therapy for targeted treatment of breast cancer
inferred← citeshttps://doi.org/10.1016/j.onano.2022.100081openalex-snapshot
Flavonoid-based nanomedicines to target tumor microenvironment
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2022.103212openalex-snapshot
Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2023.103959openalex-snapshot
Nanomaterials-assisted photothermal therapy for breast cancer: State-of-the-art advances and future perspectives
inferred← citeshttps://doi.org/10.1016/j.phymed.2021.153628openalex-snapshot
Aiduqing formula suppresses breast cancer metastasis via inhibiting CXCL1-mediated autophagy
inferred← citeshttps://doi.org/10.1016/j.pmatsci.2023.101070openalex-snapshot
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.prenap.2025.100173openalex-snapshot
Stilbenes in breast cancer treatment: Nanostilbenes an approach to improve therapeutic efficacy
inferred← citeshttps://doi.org/10.1016/j.procbio.2024.03.007openalex-snapshot
Facile fabrication of anticancer peptide coated zeolite imidazole framework for effective treatment of colorectal cancer cells and its apoptosis induction
inferred← citeshttps://doi.org/10.1016/j.prp.2024.155318openalex-snapshot
Potential roles of PIWI-interacting RNAs in breast cancer, a new therapeutic strategy
inferred← citeshttps://doi.org/10.1016/j.sajb.2024.07.026openalex-snapshot
Targeting the WWP1 gene with incensole acetate nanoemulsion: A novel therapeutic strategy for breast cancer
inferred← citeshttps://doi.org/10.1016/j.taap.2022.116036openalex-snapshot
Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancer
inferred← citeshttps://doi.org/10.1016/j.talanta.2023.124772openalex-snapshot
Chlorin e6 (Ce6)-loaded plaque-specific liposome with enhanced photodynamic therapy effect for atherosclerosis treatment
inferred← citeshttps://doi.org/10.1016/j.xphs.2021.09.018openalex-snapshot
Coupling EGFR-Antagonistic Affibody Enhanced Therapeutic Effects of Cisplatin Liposomes in EGFR-expressing Tumor Models
inferred← citeshttps://doi.org/10.1021/acs.analchem.4c05800openalex-snapshot
SERS/Fluorescence Dual-Modal Imaging Bioprobe for Accurate Diagnosis of Breast Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02263openalex-snapshot
Discovery of PKMYT1 Inhibitors with a Novel Scaffold for the Treatment of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.3c00610openalex-snapshot
Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.4c00254openalex-snapshot
Photodynamic Therapy Synergizes CD47 Blockade Strategy for Enhanced Antitumor Therapy
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00251openalex-snapshot
Development of Inorganic and Hybrid Nanosystems for Delivery of CRISPR-Based Gene Editors
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c01357openalex-snapshot
Regulation of CAF by α-Mangostin Promotes the Penetration of Nanomedicine and Inhibits the Metastasis of Breast Tumor
inferred← citeshttps://doi.org/10.1021/acsabm.4c01378openalex-snapshot
Sustainable Synthesis of Nitrogen-Embedded Cu2S Quantum Dots for In Vitro and In Vivo Breast Cancer Management
inferred← citeshttps://doi.org/10.1021/acsabm.5c00040openalex-snapshot
Manganese-Based Nanotherapeutics for Targeted Treatment of Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsabm.5c00702openalex-snapshot
Theranostic Potential of Metal–Organic Framework/Polydopamine-Modified Magnetic Nanoparticles for Photothermal/Chemotherapy and MR Imaging
inferred← citeshttps://doi.org/10.1021/acsabm.5c01098openalex-snapshot
Chondroitin Sulfate-Mediated Targeted Delivery of Docetaxel and Silibinin-Loaded Nanoparticles for Amelioration of Anticancer Efficacy in Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsami.3c01896openalex-snapshot
Thermosusceptible Nitric-Oxide-Releasing Nitrogel for Strengthening Antitumor Immune Responses with Tumor Collagen Diminution and Deep Tissue Delivery during NIR Laser-Assisted Photoimmunotherapy
inferred← citeshttps://doi.org/10.1021/acsami.3c11561openalex-snapshot
Albumin Nanoparticles Surface Decorated with a Tumor-Homing Peptide Help in Selective Killing of Triple-Negative Breast Cancer Cells
inferred← citeshttps://doi.org/10.1021/acsami.4c08842openalex-snapshot
Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy
inferred← citeshttps://doi.org/10.1021/acsanm.2c03880openalex-snapshot
Enhancing the Antitumor Efficacy of Zwitterionic Peptide-Based Nanoscale Micelles through Sensitizing Their Response in Solid Tumors
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.4c00108openalex-snapshot
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.4c00376openalex-snapshot
Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.4c01485openalex-snapshot
Improved Control of Triple-Negative Breast Cancer Tumor and Metastasis with a pH-Sensitive Hyaluronic Acid Nanocarrier for Doxorubicin Delivery
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.4c02390openalex-snapshot
Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.5c01386openalex-snapshot
Glycogen-Linked TPGS Nanomicelles for Hypoxia-Responsive PD-L1 Targeting and Molecular Imaging of Breast Tumor
inferred← citeshttps://doi.org/10.1021/acsnano.2c02965openalex-snapshot
Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy
inferred← citeshttps://doi.org/10.1021/acsnano.4c05938openalex-snapshot
Endogenous Magnetic Lipid Droplet-Mediated Cascade-Targeted Sonodynamic Therapy as an Approach to Reversing Breast Cancer Multidrug Resistance
inferred← citeshttps://doi.org/10.1021/acsomega.3c07345openalex-snapshot
Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges
inferred← citeshttps://doi.org/10.1021/acsomega.5c04309openalex-snapshot
Synergistic Effects of CoHCF@MWCNTs@FA Nanocomposites Enhancing Photodynamic Therapy for Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsomega.5c13065openalex-snapshot
Loading Density Influences the Tumor Cell Targeting and Signaling Inhibition Capabilities of Antibody Nanoconjugates
inferred← citeshttps://doi.org/10.1038/s41401-025-01673-wopenalex-snapshot
Targeting RSK2 enhances the efficacy of IGF1R inhibitor against triple-negative breast cancer via antagonizing IGF1/IGF1R signaling mediated by GATA3-IGFBP5 pathway
inferred← citeshttps://doi.org/10.1038/s41419-024-07123-5openalex-snapshot
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling
inferred← citeshttps://doi.org/10.1038/s41598-024-77414-6openalex-snapshot
pH-responsive magnetic CuFe2O4-PMAA nanogel conjugated with amino-modified lignin for controlled breast cancer drug delivery
inferred← citeshttps://doi.org/10.1039/d1ra04513jopenalex-snapshot
Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics
inferred← citeshttps://doi.org/10.1039/d1tb00354bopenalex-snapshot
Engineering of stealth (maghemite/PLGA)/chitosan (core/shell)/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer
inferred← citeshttps://doi.org/10.1039/d3bm00219eopenalex-snapshot
Administration methods of lipid-based nanoparticle delivery systems for cancer treatment
inferred← citeshttps://doi.org/10.1039/d3na00965copenalex-snapshot
Nanoparticle-mediated diagnosis, treatment, and prevention of breast cancer
inferred← citeshttps://doi.org/10.1039/d3nr00196bopenalex-snapshot
Formation of ssDNA nanotubes from spherical micelles and their use as a delivery vehicle for chemotherapeutics and senolytics to triple negative breast cancer cells
inferred← citeshttps://doi.org/10.1039/d3nr04305copenalex-snapshot
Intracellular self-aggregation of biomimetic Fe 3 O 4 nanoparticles for enhanced ferroptosis-inducing therapy of breast cancer
inferred← citeshttps://doi.org/10.1039/d3ra03753copenalex-snapshot
Preparation of Gd-doped AuNBP@mSiO 2 nanocomposites for the MR imaging, drug delivery and chemo-photothermal synergistic killing of breast cancer cells
inferred← citeshttps://doi.org/10.1039/d4na00488dopenalex-snapshot
Revolutionizing cancer therapy: nanoformulation of miRNA-34 – enhancing delivery and efficacy for various cancer immunotherapies: a review
inferred← citeshttps://doi.org/10.1039/d4nr02382jopenalex-snapshot
A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy
inferred← citeshttps://doi.org/10.1039/d4ra02639jopenalex-snapshot
Nanoscale strides: exploring innovative therapies for breast cancer treatment
inferred← citeshttps://doi.org/10.1039/d4tb00002aopenalex-snapshot
Homologous polydopamine ameliorates haemolysis of melittin for enhancing its anticancer efficacy
inferred← citeshttps://doi.org/10.1039/d5na00341eopenalex-snapshot
Green-synthesized silver nanoparticles from incensole acetate modulate TPX2 expression in DMBA-induced breast cancer
inferred← citeshttps://doi.org/10.1039/d5na00776copenalex-snapshot
Synthesis of Pluronic F127 copolymer/iron oxide–GelMA nanocomposite for doxorubicin drug delivery
inferred← citeshttps://doi.org/10.1039/d5pm00265fopenalex-snapshot
Recent advances in electrospun nanofiber-based implantable drug delivery systems for breast cancer therapy
inferred← citeshttps://doi.org/10.1039/d5ra07279dopenalex-snapshot
Multi-functionalized biologically active isatin-tagged dihydropyrimidine derivatives: green synthesis by the use of recyclable Fe-dopped Ce-oxide nanoparticles, computational studies and ex vivo cytotoxic activity against breast cancer cells
inferred← citeshttps://doi.org/10.1039/d5tb00768bopenalex-snapshot
Inducing ferroptosis in breast cancer with nanoparticles: a promising and challenging therapeutic strategy
inferred← citeshttps://doi.org/10.1080/00222348.2025.2537449openalex-snapshot
Hyaluronic Acid-Polyethylene Glycol-Polycaprolactone Nanocarriers: Accurate Targeting and Multimodal Treatment for Aggressive Cancers
inferred← citeshttps://doi.org/10.1080/03639045.2025.2604646openalex-snapshot
Current developments and future directions in androgen receptor targets using nano-based therapeutics for the management of cancer
inferred← citeshttps://doi.org/10.1080/1061186x.2022.2062598openalex-snapshot
Nanoreactor activated in situ for starvation-chemodynamic therapy of breast cancer
inferred← citeshttps://doi.org/10.1080/1061186x.2023.2245579openalex-snapshot
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1080/10717544.2022.2056662openalex-snapshot
Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity
inferred← citeshttps://doi.org/10.1080/10717544.2022.2079770openalex-snapshot
Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management
inferred← citeshttps://doi.org/10.1080/13880209.2025.2511807openalex-snapshot
Hyaluronic acid-engineered milk extracellular vesicles to target triple negative breast cancer through CD44
inferred← citeshttps://doi.org/10.1080/14728222.2022.2094762openalex-snapshot
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
inferred← citeshttps://doi.org/10.1080/15440478.2026.2702574openalex-snapshot
Stevia-Capped Silver Nanoparticles with Tunable Optical Band Gap and Enhanced Cytotoxicity Toward MCF-7 Cells
inferred← citeshttps://doi.org/10.1080/17425247.2024.2317194openalex-snapshot
Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
inferred← citeshttps://doi.org/10.1080/17435889.2024.2347825openalex-snapshot
Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells
inferred← citeshttps://doi.org/10.1080/20415990.2024.2400044openalex-snapshot
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer
inferred← citeshttps://doi.org/10.1080/20415990.2025.2527577openalex-snapshot
Styrene-maleic acid-thymoquinone nanomicelles preparation, and their in vitro and in vivo application in a model of TNBC
inferred← citeshttps://doi.org/10.1088/2053-1591/abed89openalex-snapshot
Construction of the targeted and pH-sensitive paclitaxel drug delivery system RGD/PTX@ZIF-90 and anti-tumor activity research
inferred← citeshttps://doi.org/10.1097/md.0000000000039845openalex-snapshot
Triple-negative breast cancer treatment with core-shell Magnetic@Platinium-Metal organic framework/epirubicin nano-platforms for chemo-photodynamic based combinational therapy: A review
inferred← citeshttps://doi.org/10.1142/s2737416524500716openalex-snapshot
Chitosomal Encapsulation Enhances the Anticancer Efficacy of a Theobromine Analogue: An Integrated In Silico and In Vitro Study
inferred← citeshttps://doi.org/10.1177/11782234251365941openalex-snapshot
Prospects and Challenges of Different Delivery Systems in Breast Tumors Therapy
inferred← citeshttps://doi.org/10.1177/1934578x251384515openalex-snapshot
Exploring the Anticancer Potential of Chitosome-Encapsulated Theobromine Analogue: Integrated Computational, Physiochemical and In vitro Study
inferred← citeshttps://doi.org/10.1186/s11658-025-00738-2openalex-snapshot
The novel tRNA-derived fragment, tiRNA-Met, inhibits the malignant progression of triple-negative breast cancer by regulating RANBP3L via a targeted interaction with SNRPA
inferred← citeshttps://doi.org/10.1186/s11671-024-03985-yopenalex-snapshot
Targeting triple negative breast cancer stem cells using nanocarriers
inferred← citeshttps://doi.org/10.1186/s11671-024-04089-3openalex-snapshot
The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date)
inferred← citeshttps://doi.org/10.1186/s11671-024-04122-5openalex-snapshot
Tumor microenvironment–responsive nanoformulations for breast cancer
inferred← citeshttps://doi.org/10.1186/s12645-021-00093-9openalex-snapshot
Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition
inferred← citeshttps://doi.org/10.1186/s12951-025-03302-4openalex-snapshot
Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine
inferred← citeshttps://doi.org/10.1186/s43094-025-00923-2openalex-snapshot
A marvelous hope in the treatment of breast cancer: Moorena producens as an incredible source of bioactive metabolites with a variety of unique selective molecular mechanisms
inferred← citeshttps://doi.org/10.1208/s12249-023-02712-7openalex-snapshot
Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.12794/metadc2179329openalex-snapshot
Design and Synthesis of Gold (I) Acyclic Diamino Carbene Complexes as Metallodrugs for Cancer and for Asymmetric Catalysis
showing the first 200 of 289 · page through all 289
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.